Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial

PURPOSE: To report the results of the Single Fraction Early Prostate Irradiation (SiFEPI) phase 2 prospective trial. MATERIALS/METHODS: The SiFEPI trial (NCT02104362) evaluated a single fraction of high-dose rate brachytherapy (HDB) for low- (LR) and favorable-intermediate (FIR) risk prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannoun-Levi, Jean-Michel, Chand-Fouche, Marie-Eve, Pace-Loscos, Tanguy, Gautier, Mathieu, Gal, Jocelyn, Schiappa, Renaud, Pujol, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449500/
https://www.ncbi.nlm.nih.gov/pubmed/36093342
http://dx.doi.org/10.1016/j.ctro.2022.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449500/
https://www.ncbi.nlm.nih.gov/pubmed/36093342
http://dx.doi.org/10.1016/j.ctro.2022.08.007

Ejemplares similares